Pemafibrate for primary biliary cholangitis with dyslipidemia: A proposal of a new treatment from Japan

Hepatology ResearchVolume 52, Issue 6 p. 495-496 EDITORIAL Pemafibrate for primary biliary cholangitis with dyslipidemia: A proposal of a new treatment from Japan Naoki Tanaka, Corresponding Author Naoki Tanaka naopi@shinshu-u.ac.jp orcid.org/0000-0002-3212-3836 Department of Global Medical Research Promotion, Shinshu University Graduate School of Medicine, Matsumoto, Japan International Relations Office, Shinshu University School of Medicine, Matsumoto, Japan Research Center for Social Systems, Shinshu University, Matsumoto, Japan Correspondence Naoki Tanaka, Department of Global Medical Research Promotion, Shinshu University Graduate School of Medicine, Matsumoto, Nagano 390-8621, Japan. Email: naopi@shinshu-u.ac.jp and Akira Honda, Division of Gastroenterology and Hepatology, Tokyo Medical University Ibaraki Medical Center, Ibaraki 300-0395, Japan. Email: akihonda@tokyo-med.ac.jpSearch for more papers by this authorAkira Honda, Corresponding Author Akira Honda akihonda@tokyo-med.ac.jp orcid.org/0000-0003-0902-8272 Division of Gastroenterology and Hepatology, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan Joint Research Center, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan Correspondence Naoki Tanaka, Department of Global Medical Research Promotion, Shinshu University Graduate School of Medicine, Matsumoto, Nagano 390-8621, Japan. Email: naopi@shinshu-u.ac.jp and Akira Honda, Division of Gastroenterology and Hepatology, Tokyo Medical University Ibaraki Medical Center, Ibaraki 300-0395, Japan. Email: akihonda@tokyo-med.ac.jpSearch for more papers by this author Naoki Tanaka, Corresponding Author Naoki Tanaka naopi@shinshu-u.ac.jp orcid.org/0000-0002-3212-3836 Department of Global Medical Research Promotion, Shinshu University Graduate School of Medicine, Matsumoto, Japan International Relations Office, Shinshu University School of Medicine, Matsumoto, Japan Research Center for Social Systems, Shinshu University, Matsumoto, Japan Correspondence Naoki Tanaka, Department of Global Medical Research Promotion, Shinshu University Graduate School of Medicine, Matsumoto, Nagano 390-8621, Japan. Email: naopi@shinshu-u.ac.jp and Akira Honda, Division of Gastroenterology and Hepatology, Tokyo Medical University Ibaraki Medical Center, Ibaraki 300-0395, Japan. Email: akihonda@tokyo-med.ac.jpSearch for more papers by this authorAkira Honda, Corresponding Author Akira Honda akihonda@tokyo-med.ac.jp orcid.org/0000-0003-0902-8272 Division of Gastroenterology and Hepatology, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan Joint Research Center, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan Correspondence Naoki Tanaka, Department of Global Medical Research Promotion, Shinshu University Graduate School of Medicine, Matsumoto, Nagano 390-8621, Japan. Email: naopi@shinshu-u.ac.jp and Akira Honda, Division of Gastroenterology and Hepatology, Tokyo Medical University Ibaraki Medical Center, Ibaraki 300-0395, Japan. Email: akihonda@tokyo-med.ac.jpSearch for more papers by this author First published: 01 June 2022 https://doi.org/10.1111/hepr.13770Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article. Volume52, Issue6June 2022Pages 495-496 RelatedInformation